Department of Anesthesiology, University Hospital Regensburg, Regensburg, Germany.
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1488-95. doi: 10.1016/j.jtcvs.2011.01.034. Epub 2011 Mar 3.
Malignant hyperthermia susceptibility is an important risk factor during general anesthesia. Affected patients have an asymptomatic but potentially lethal hypermetabolic reaction after contact with volatile anesthetics or succinylcholine. Classic symptoms include hemodynamic instability, combined with acidosis, rigor, and hyperthermia. During cardiopulmonary bypass, these signs may be obscured, delaying correct diagnosis and lifesaving treatment. Malignant hyperthermia-susceptible individuals are more sensitive to heat and stress, so rewarming and catecholamine administration may trigger an episode, necessitating prophylactic measures.
This systematic review identified typical malignant hyperthermia symptoms during cardiopulmonary bypass and investigated other factors in cardiac surgery that might trigger an episode in susceptible individuals. Approaches used to treat and prevent malignant hyperthermia during cardiopulmonary bypass were systematically analyzed. We conducted a systematic search for reports about malignant hyperthermia and cardiopulmonary bypass. Search terms included malignant hyperthermia and cardiopulmonary bypass, extracorporeal circulation, or cardiac surgery.
We found 24 case reports and case series including details of 26 patients. In 14 cases, malignant hyperthermia crises during or shortly after cardiopulmonary bypass were described. Fourteen reports discussed prevention of an episode. Early symptoms of a malignant hyperthermia episode include excessive carbon dioxide production and metabolic acidosis. Massively increased creatine kinase levels are a strong indicator of a malignant hyperthermia reaction. Rewarming is associated with development of clinical signs of malignant hyperthermia.
In potentially susceptible patients, apart from avoiding classic trigger substances, aggressive rewarming should not be applied. Hemodynamic instability in conjunction with the described symptoms should result in a diagnostic algorithm.
恶性高热易感性是全身麻醉期间的一个重要危险因素。受影响的患者在接触挥发性麻醉剂或琥珀酰胆碱后会发生无症状但潜在致命的代谢亢进反应。典型症状包括血流动力学不稳定,伴有酸中毒、肌强直和高热。在体外循环期间,这些迹象可能会被掩盖,从而延迟正确的诊断和救生治疗。恶性高热易感个体对热和应激更为敏感,因此复温和儿茶酚胺给药可能会引发发作,需要采取预防措施。
本系统评价确定了体外循环期间恶性高热的典型症状,并研究了心脏手术中可能引发易感个体发作的其他因素。系统分析了体外循环期间治疗和预防恶性高热的方法。我们对关于恶性高热和体外循环的报告进行了系统搜索。搜索词包括恶性高热和体外循环、体外循环或心脏手术。
我们发现了 24 份病例报告和病例系列,其中包括 26 名患者的详细信息。在 14 例中,描述了体外循环期间或之后不久发生的恶性高热危象。14 份报告讨论了发作的预防。恶性高热发作的早期症状包括二氧化碳产生过多和代谢性酸中毒。肌酸激酶水平的大量增加是恶性高热反应的强烈指标。复温与恶性高热临床症状的发展有关。
在潜在易感患者中,除了避免经典的触发物质外,不应采用积极的复温。血流动力学不稳定伴有描述的症状应导致诊断算法。